Research output per year
Research output per year
Research activity per year
Ischaemic heart disease: diabetic heart disease; VTE disease
Previous research: Genetics and immunology in Type 1 diabetes. DMSc in this subject 2005.
Non-commercial : Effects of liraglutide in patients with stable coronary disease - focus on both heart and metabolic parameters.
Company-initated studies on VTE (Bayer AS) and diabetic medication in heart disease (Bayer, Novartis)
Currently I am involved in studies related to the metabolic (endocrine) effects and effect on heart function of liraglutide in patients with stable coronary disease.
Commercial studies are related to long term treatment with rivaroxaban in patients with VTE (Bayer AS), effects of an GLP-1 agonist in patients with stable coronary disease (GSK)
Not stockholder in any companies involved in production of medical products.
Have performed company sponsored studies for Bayer AS, Novartis, GSK.
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to journal › Journal article › Research › peer-review